Trial Profile
Comparison of ciclesonide (80 mcg once daily in the evening) and fluticasone propionate (100 mcg twice daily) in patients with mild to moderate asthma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Dec 2016
Price :
$35
*
At a glance
- Drugs Ciclesonide (Primary) ; Fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 04 May 2012 'Takeda Global Research and Development Center' added as trial sponsor and lead trial centre as reported by ClinicalTrials.gov.
- 12 Jul 2011 New source identified and integrated (European Clinical Trials Database)
- 31 Mar 2010 Results were published in Respiratory Medicine.